RMD
ResMed Inc
221.90$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +43.0% | -24.4% | +22.0% | -9.1% | +74.8% | -8.2% | -52.3% | +97.4% | +102.1% | +25.0% | +3.1% | |
| – | +18.9% | +29.1% | +7.0% | +25.7% | +20.3% | +5.6% | +1.2% | +1.9% | +9.4% | +9.1% | +3.5% | |
| – | -3.0% | -1.0% | +5.4% | +7.6% | +10.5% | +11.1% | +2.1% | +9.0% | +12.7% | +14.3% | +13.8% | |
| – | +113.0% | +23.3% | +4.2% | +33.6% | +2.3% | -16.1% | +24.0% | -29.8% | – | – | – | |
| – | – | -245.7% | – | -2,053.8% | – | – | -50,496.9% | – | – | -62.6% | -543.6% | |
| – | -5.7% | +5.4% | 0.0% | +8.2% | +37.0% | +10.3% | +33.6% | -14.1% | -14.3% | -21.8% | +73.9% | |
| – | +686.8% | -92.7% | +24.3% | +956.4% | -83.3% | -11.9% | +45.1% | +404.5% | -76.7% | -25.8% | +172.5% | |
| – | +6.9% | +10.8% | +7.1% | +6.1% | +6.3% | +0.7% | +8.2% | +5.3% | +9.3% | +10.1% | +12.5% | |
| – | -36.3% | +0.0% | -47.3% | -57.5% | – | -92.4% | -47.4% | +2,158.1% | -114.0% | +100.0% | +133.3% | |
| – | – | -111.1% | +738.1% | – | -111.6% | +455.2% | – | +445.1% | -209.8% | -94.5% | -75.0% | |
| – | – | -142.9% | +290.6% | – | -154.6% | +141.0% | -83.2% | – | -364.7% | -45.8% | +66.1% | |
| – | – | +538.0% | -799.7% | – | – | -153.1% | – | – | – | +9,175.0% | -73.2% | |
| – | +54.3% | -28.6% | +26.6% | -12.0% | +82.4% | -11.0% | -68.5% | +186.7% | +130.0% | +29.2% | -0.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.